Citation

  • Authors: Tang, H., Du, W., Jiang, Y., Li, H., Bo, H., Song, S.
  • Year: 2019
  • Journal: J Cell Physiol
  • Applications: in vitro / mimic miRNA and DNA cotransfection, siRNA / jetPRIME
  • Cell types:
    1. Name: A549
      Description: Human lung carcinoma cells, type II pneumocytes
      Known as: A-549
    2. Name: SPC-A1
      Description: Human lung adenocarcinoma
      Known as: SPC-A-1 ; SPCA-1 ; SPCA1

Method

100 pmol siRNA + 5 µL jetPRIME in 6-well plate

Abstract

Lung cancer is regarded as one of the dominant causes in cancer patients among men and women all over the world. Rho-associated coiled-coil forming protein kinase l (ROCK1) is characterized as pivotal downstream effectors of the small GTPase RhoA and reported to participate in tumor metastasis. miR-335-5p acts as tumor suppressor microRNA and is identified to be downregulated in tumor tissues. miR-335-5p/ROCK1 axis has been demonstrated to promote cell proliferation and metastasis in gastric cancer, hepatocellular carcinoma and so on. However, the role it plays in promoting cell proliferation in non-small cell lung cancer (NSCLC) is poorly understood. Here, we demonstrated that the upregulated expression of ROCK1 was highly correlated with downregulated expression of miR-335-5p in NSCLC tissues and cell lines. Mechanistically, Knockdown of ROCK1 inhibited cell proliferation in vitro, accompanied by cell cycle change confirmed by flow analysis. Furthermore, miR-335-5p can downregulate the ROCK1 expression by directly binding to the 3'-untranslated region in posttranscriptional level. In vivo animal model showed similar results. Our findings highlighted the crucial role that miR-335-5p acted as a tumor suppressor to modulate cell proliferation and cell cycle progression via downregulating ROCK1 expression. And this miR-335-5p/ROCK1 axis contributed to NSCLC pathogenesis and might be promising targets for NSCLC therapy.

Go to